Introduction OncoSenX is a company that specializes in creating transient gene therapies for solid tumors. Their innovative approach involves using a novel lipid nanoparticle to deliver plasmid DNA, which selectively targets and destroys cancerous cells based on their transcriptional activity. This groundbreaking therapy offers a minimally invasive and highly precise alternative for treating cancer, providing hope for patients, doctors, and medical professionals alike in the fight against this challenging disease. |